Full disclosure: I am a founding engineer at this company. Imo typing is just the most relevant part of the system for how the SDK feels for the developer. The

Full disclosure: I am a founding engineer at this company. Imo typing is just the most relevant part of the system for how the SDK feels for the developer. The fundamental problems we currently solve are more so related to reproducibility and software rot in particular, and to working with terabyte scale data which is almost universal in bioinformatics. The SDK lets you get a pretty good interface to an arbitrary sized compute node with a native interface to S3, and types make it basically effortless. I'd love to hear what other problems you think need to be addressed. We've been in business for less than a year, naturally there is still a lot of work to do.